Younes Smani

2.6k total citations
70 papers, 1.9k citations indexed

About

Younes Smani is a scholar working on Molecular Medicine, Molecular Biology and Pharmacology. According to data from OpenAlex, Younes Smani has authored 70 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Molecular Medicine, 23 papers in Molecular Biology and 21 papers in Pharmacology. Recurrent topics in Younes Smani's work include Antibiotic Resistance in Bacteria (47 papers), Antibiotics Pharmacokinetics and Efficacy (19 papers) and Vibrio bacteria research studies (13 papers). Younes Smani is often cited by papers focused on Antibiotic Resistance in Bacteria (47 papers), Antibiotics Pharmacokinetics and Efficacy (19 papers) and Vibrio bacteria research studies (13 papers). Younes Smani collaborates with scholars based in Spain, France and Bulgaria. Younes Smani's co-authors include Jerónimo Pachón, Juan Domínguez-Herrera, Rafael Ayerbe-Algaba, Andrea Miró-Canturri, Michael J. McConnell, María Eugenia Pachón-Ibáñez, Rafael López-Rojas, Fernando Docobo-Pérez, Viviana Sánchez-Encinales and Jordi Vilà and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Younes Smani

69 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Younes Smani Spain 24 1.1k 727 512 302 289 70 1.9k
Paul Pantapalangkoor United States 13 1.1k 1.0× 507 0.7× 586 1.1× 172 0.6× 247 0.9× 16 1.6k
Travis B. Nielsen United States 20 990 0.9× 776 1.1× 517 1.0× 136 0.5× 259 0.9× 40 2.1k
Javier Sánchez‐Céspedes Spain 21 651 0.6× 506 0.7× 281 0.5× 152 0.5× 203 0.7× 51 1.4k
Andrew P. Tomaras United States 26 1.7k 1.5× 1.5k 2.1× 926 1.8× 227 0.8× 282 1.0× 38 2.7k
Christian M. Harding United States 17 1.2k 1.0× 834 1.1× 763 1.5× 179 0.6× 261 0.9× 25 1.8k
Simona Pollini Italy 25 877 0.8× 756 1.0× 259 0.5× 321 1.1× 223 0.8× 45 2.0k
Tsuey‐Ching Yang Taiwan 28 570 0.5× 907 1.2× 902 1.8× 163 0.5× 243 0.8× 86 2.2k
Samuel Bellais France 25 1.0k 0.9× 773 1.1× 660 1.3× 98 0.3× 416 1.4× 33 2.0k
Michelle K. Paczosa United States 8 926 0.8× 554 0.8× 392 0.8× 113 0.4× 329 1.1× 9 1.7k
Weihui Wu China 27 765 0.7× 1.3k 1.8× 445 0.9× 246 0.8× 211 0.7× 120 2.2k

Countries citing papers authored by Younes Smani

Since Specialization
Citations

This map shows the geographic impact of Younes Smani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Younes Smani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Younes Smani more than expected).

Fields of papers citing papers by Younes Smani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Younes Smani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Younes Smani. The network helps show where Younes Smani may publish in the future.

Co-authorship network of co-authors of Younes Smani

This figure shows the co-authorship network connecting the top 25 collaborators of Younes Smani. A scholar is included among the top collaborators of Younes Smani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Younes Smani. Younes Smani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hmadcha, Abdelkrim, et al.. (2025). Antibacterial activity of tamoxifen derivatives against methicillin-resistant Staphylococcus aureus. Frontiers in Pharmacology. 16. 1549288–1549288. 1 indexed citations
2.
Vladkova, T., et al.. (2024). Recent Progress in Terrestrial Biota-Derived Anti-Biofilm Agents for Medical Applications. SHILAP Revista de lepidopterología. 4(3). 1362–1383. 2 indexed citations
3.
Cisneros, José Miguel, et al.. (2023). In Vitro and In Vivo Virulence Study of Listeria monocytogenes Isolated from the Andalusian Outbreak in 2019. Tropical Medicine and Infectious Disease. 8(1). 58–58. 4 indexed citations
4.
Gálvez-Benítez, Lydia, et al.. (2022). Ultrasensitive and rapid identification of ESRI developer- and piperacillin/tazobactam-resistant Escherichia coli by the MALDIpiptaz test. Emerging Microbes & Infections. 11(1). 2034–2044. 4 indexed citations
5.
Gómez, Gorka, Abdelkrim Hmadcha, Julio Sotelo, et al.. (2022). Tissue engineered in-vitro vascular patch fabrication using hybrid 3D printing and electrospinning. Materials Today Bio. 14. 100252–100252. 28 indexed citations
6.
Miró-Canturri, Andrea, et al.. (2021). Repurposing of the Tamoxifen Metabolites to Treat Methicillin-Resistant Staphylococcus epidermidis and Vancomycin-Resistant Enterococcus faecalis Infections. Microbiology Spectrum. 9(2). e0040321–e0040321. 6 indexed citations
7.
Miró-Canturri, Andrea, et al.. (2021). Repurposing of the Tamoxifen Metabolites to Combat Infections by Multidrug-Resistant Gram-Negative Bacilli. Antibiotics. 10(3). 336–336. 10 indexed citations
8.
Miró-Canturri, Andrea, Rafael Ayerbe-Algaba, R. Toro, et al.. (2021). Potential Tamoxifen Repurposing to Combat Infections by Multidrug-Resistant Gram-Negative Bacilli. Pharmaceuticals. 14(6). 507–507. 7 indexed citations
9.
Miró-Canturri, Andrea, Rafael Ayerbe-Algaba, Jiménez-Mejías Me, Jerónimo Pachón, & Younes Smani. (2021). Efficacy of Lysophosphatidylcholine as Direct Treatment in Combination with Colistin against Acinetobacter baumannii in Murine Severe Infections Models. Antibiotics. 10(2). 194–194. 6 indexed citations
10.
Ayerbe-Algaba, Rafael, et al.. (2020). Antibacterial Activity of Colloidal Silver against Gram-Negative and Gram-Positive Bacteria. DIGITAL.CSIC (Spanish National Research Council (CSIC)). 74 indexed citations
11.
Espinal, Paula, Alix Pantel, Dora Rolo, et al.. (2019). Relationship Between Different Resistance Mechanisms and Virulence in Acinetobacter baumannii. Microbial Drug Resistance. 25(5). 752–760. 15 indexed citations
12.
Vila‐Farrés, Xavier, Rafael Ayerbe-Algaba, Mónica Varese, et al.. (2018). Synergistic activity of an OmpA inhibitor and colistin against colistin-resistant Acinetobacter baumannii: mechanistic analysis and in vivo efficacy. Journal of Antimicrobial Chemotherapy. 73(12). 3405–3412. 31 indexed citations
13.
Pachón-Ibáñez, María Eugenia, Caridad Díaz, Younes Smani, et al.. (2018). Efficacy of Colistin and Its Combination With Rifampin in Vitro and in Experimental Models of Infection Caused by Carbapenemase-Producing Clinical Isolates of Klebsiella pneumoniae. Frontiers in Microbiology. 9. 912–912. 19 indexed citations
14.
Vila‐Farrés, Xavier, Viviana Sánchez-Encinales, Mónica Varese, et al.. (2017). Combating virulence of Gram-negative bacilli by OmpA inhibition. Scientific Reports. 7(1). 14683–14683. 63 indexed citations
15.
Sánchez-Encinales, Viviana, Rocío Álvarez‐Marín, María Eugenia Pachón-Ibáñez, et al.. (2017). Overproduction of outer membrane protein A (OmpA) by Acinetobacter baumannii is a risk factor for nosocomial pneumonia, bacteremia and mortality increase.. The Journal of Infectious Diseases. 215(6). jix010–jix010. 56 indexed citations
16.
Pachón-Ibáñez, María Eugenia, Younes Smani, Jerónimo Pachón, & Javier Sánchez‐Céspedes. (2017). Perspectives for clinical use of engineered human host defense antimicrobial peptides. FEMS Microbiology Reviews. 41(3). 323–342. 118 indexed citations
17.
Me, Jiménez-Mejías, Viviana Sánchez-Encinales, Rafael Ayerbe-Algaba, et al.. (2016). Efficacy of Lysophosphatidylcholine in Combination with Antimicrobial Agents against Acinetobacter baumannii in Experimental Murine Peritoneal Sepsis and Pneumonia Models. Antimicrobial Agents and Chemotherapy. 60(8). 4464–4470. 35 indexed citations
18.
Smani, Younes, et al.. (2015). Therapeutic Efficacy of Lysophosphatidylcholine in Severe Infections Caused by Acinetobacter baumannii. Antimicrobial Agents and Chemotherapy. 59(7). 3920–3924. 39 indexed citations
19.
Smani, Younes, Juan Domínguez-Herrera, & Jerónimo Pachón. (2013). Association of the Outer Membrane Protein Omp33 With Fitness and Virulence of Acinetobacter baumannii. The Journal of Infectious Diseases. 208(10). 1561–1570. 107 indexed citations
20.
Smani, Younes, Juan Domínguez-Herrera, & Jerónimo Pachón. (2011). Rifampin Protects Human Lung Epithelial Cells Against Cytotoxicity Induced by Clinical Multi and Pandrug-resistant Acinetobacter baumannii. The Journal of Infectious Diseases. 203(8). 1110–1119. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paul Pantapalangkoor Breakdown of academic impact, for papers by Travis B. Nielsen Breakdown of academic impact, for papers by Javier Sánchez‐Céspedes Breakdown of academic impact, for papers by Andrew P. Tomaras Breakdown of academic impact, for papers by Christian M. Harding Breakdown of academic impact, for papers by Simona Pollini Breakdown of academic impact, for papers by Tsuey‐Ching Yang Breakdown of academic impact, for papers by Samuel Bellais Breakdown of academic impact, for papers by Michelle K. Paczosa Breakdown of academic impact, for papers by Weihui Wu
Rankless by CCL
2026